Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Dobesilate vs Cabergoline for OHSS Prevention
NCT02271360Phase 3Completed
- Sponsor
- Benha University
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcium dobesilate in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Benha University. Primary endpoint: Number of participants with ovarian hyperstimulation syndrome at 8 weeks. Started Apr 2014; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02271360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271360.